Stryker Corporation falls short of quarterly estimates amid softer demand for medical devices

Stryker Corporation on Thursday maintained its full-year profit outlook but fell short of Wall Street expectations for first-quarter revenue and earnings, as …

Merck & Co. surpasses quarterly sales forecasts, driven by strong growth from Keytruda

Merck & Co. said on Thursday it exceeded first-quarter sales expectations, driven by strong demand for its flagship cancer immunotherapy Keytruda, sending …

LEO Pharma agrees to acquire U.S. drug developer Replay for an upfront payment of $50 million

Danish drugmaker LEO Pharma said on Thursday it had agreed to acquire U.S.-based drug developer Replay for an upfront payment of $50 …

Seaport Therapeutics secures approximately $255 million through an upsized IPO

Drug developer Seaport Therapeutics announced on Thursday that it had raised approximately $255 million through its upsized initial public offering in the …

Babesiosis Explained: Causes, Symptoms, Treatment and Prevention of This Tick-Borne Disease

Babesiosis is a tick-borne infectious disease caused by microscopic parasites that infect red blood cells. Although it is not as widely known …

AstraZeneca to invest $405 million in the UK following new U.S.–UK pharmaceutical agreement

Keir Starmer said on Wednesday that Britain’s largest company, AstraZeneca, will invest £300 million (about $405 million) in the country after having …